A detailed history of Marotta Asset Management transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Marotta Asset Management holds 17,352 shares of BHC stock, worth $128,231. This represents 0.03% of its overall portfolio holdings.

Number of Shares
17,352
Previous 17,552 1.14%
Holding current value
$128,231
Previous $122,000 15.57%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$5.22 - $8.26 $1,044 - $1,652
-200 Reduced 1.14%
17,352 $141,000
Q2 2024

Jul 17, 2024

SELL
$6.1 - $10.41 $3,355 - $5,725
-550 Reduced 3.04%
17,552 $122,000
Q1 2024

Apr 02, 2024

SELL
$7.77 - $10.61 $11,064 - $15,108
-1,424 Reduced 7.29%
18,102 $192,000
Q4 2023

Jan 03, 2024

SELL
$6.53 - $8.23 $1,756 - $2,213
-269 Reduced 1.36%
19,526 $156,000
Q3 2023

Oct 11, 2023

SELL
$7.69 - $9.71 $1,307 - $1,650
-170 Reduced 0.85%
19,795 $162,000
Q2 2023

Jul 05, 2023

SELL
$5.72 - $8.8 $3,237 - $4,980
-566 Reduced 2.76%
19,965 $159,000
Q4 2022

Jan 03, 2023

BUY
$6.09 - $7.93 $2,259 - $2,942
371 Added 1.84%
20,531 $0
Q3 2022

Oct 11, 2022

SELL
$4.58 - $9.21 $2,830 - $5,691
-618 Reduced 2.97%
20,160 $138,000
Q2 2022

Jul 21, 2022

SELL
$7.06 - $23.63 $9,163 - $30,671
-1,298 Reduced 5.88%
20,778 $173,000
Q1 2022

Apr 08, 2022

SELL
$21.6 - $27.79 $9,482 - $12,199
-439 Reduced 1.95%
22,076 $504,000
Q4 2021

Jan 13, 2022

SELL
$23.0 - $29.01 $3,657 - $4,612
-159 Reduced 0.7%
22,515 $621,000
Q3 2021

Oct 21, 2021

BUY
$25.04 - $30.06 $14,297 - $17,164
571 Added 2.58%
22,674 $631,000
Q2 2021

Jul 09, 2021

BUY
$27.43 - $32.7 $117,318 - $139,857
4,277 Added 23.99%
22,103 $648,000
Q1 2021

Apr 09, 2021

BUY
$21.37 - $34.38 $380,941 - $612,857
17,826 New
17,826 $565,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Marotta Asset Management Portfolio

Follow Marotta Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marotta Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Marotta Asset Management with notifications on news.